Carol Parise

Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype

Katrina Bauer, Monica Brown, Rosemary D. Cress et al. · Cancer · 2007 · 2K citations

Breast Oncology, Progesterone Receptor, Epidemiology Of Cancer +21

Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004

Carol Parise, Katrina Bauer, Monica Brown et al. · The Breast Journal · 2009 · 323 citations

Breast Oncology, Progesterone Receptor, Cancer Epidemiology +14

Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers

Carol Parise, Vincent Caggiano · Journal of Cancer Epidemiology · 2014 · 262 citations · Full text

Breast Oncology, Cancer Epidemiology, Tumor Grade +15

The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor‐negative, invasive breast cancer: The California Cancer Registry, 1999–2004

Monica Brown, Alex Tsodikov, Katrina Bauer et al. · Cancer · 2008 · 220 citations · Full text

Platelet-Rich Fibrin Matrix in the Management of Arthroscopic Repair of the Rotator Cuff

Stephen C. Weber, Jeffrey I. Kauffman, Carol Parise et al. · The American Journal of Sports Medicine · 2012 · 189 citations